Top compounds associated with response to NAT9


Feature Type Standardized
Nominal ANOVA
mRNA SB-525334 CTRPv2 pan-cancer AAC 0.071 0.05
mRNA BRD-A94377914 CTRPv2 pan-cancer AAC -0.084 0.05
mRNA CIL70 CTRPv2 pan-cancer AAC 0.092 0.05
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.067 0.05
mRNA Crizotinib gCSI pan-cancer AAC 0.11 0.06
mRNA BRD-K33514849 CTRPv2 pan-cancer AAC 0.23 0.06
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.068 0.06
mRNA Erlotinib GDSC1000 pan-cancer AAC 0.092 0.06
mRNA Rapamycin gCSI pan-cancer AAC -0.11 0.06
mRNA BRD-K79669418 CTRPv2 pan-cancer AAC 0.1 0.06
Download CSV